AzTrials
AzTrials

Cesarean Wound RepairADTIDNCT06760026

Cosmetic Results With Tissue Adhesive vs. Subdermal Sutures in Cesarean Section

A study testing 2-octyl cyanoacrylate tissue adhesive applied continuously over the Pfannenstiel-type cesarean incision and subdermal suture in people with Cesarean Wound Repair and Cesarean Section Scar, run by Ricardo A Gutierrez Ramirez, MD, MSc, FACOG at 1 site in Honduras.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Morbidity associated with post-cesarean wound closure, including cosmetically unfavorable scarring, is a significant concern in obstetrics, impacting patient satisfaction and recovery. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
What is being tested?
2-octyl cyanoacrylate tissue adhesive applied continuously over the Pfannenstiel-type cesarean incision and subdermal suture
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteHonduras
Study dates
1 Jan 2025to 30 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Submission of a signed and dated informed consent form.
  • Declared willingness to comply with all study procedures and availability for the duration of the study.
  • Pregnant patient at 37 or more weeks gestation, scheduled for elective cesarean section at the Hospital Materno Infantil.
  • Cesarean section performed in the Maternity and Children's Hospital, operating room.
  • Literate patient, able to understand and respond to the study questions, with body mass index less than 30.
  • Possess cell phone or other means of communication to facilitate postoperative follow-up.
  • Residing in the city of Tegucigalpa, Honduras, to ensure accessibility to scheduled follow-up visits.

Who cannot join

  • Patients under 18 years of age.
  • Patients with diagnosed psychiatric illnesses that may interfere with their ability to give informed consent or follow the study protocol.
  • Pregnant patients with complications that may affect the healing process or increase the risk of postoperative complications, such as severe preeclampsia.
  • Diabetes.
  • Collagen diseases.
  • Autoimmune diseases (rheumatoid arthritis, Crohn's disease).
Show all 14Show fewer
  • Vascular diseases (vasculitis).
  • Coagulation disorders (thrombophilia).
  • Pregnant patients with premature rupture of membranes, since this may influence the choice of timing and method of cesarean section.
  • Pregnant patients diagnosed with chorioamnionitis, which represents an increased risk of postoperative infection.
  • Pregnant patients diagnosed with acute abdomen, which may require emergency surgical management that is not compatible with standard cesarean section procedures.
  • Pregnant patients with multiple pregnancies, since this could complicate the cesarean section procedure and affect the results of the study.
  • Presence of major fetal malformations that may require additional interventions at birth.
  • Fetal stillbirth

Trial locations and contacts

1 site in 1 country.

Honduras1 site
  • Hospital Escuela

    Tegucigalpa, Francisco Morazán Department, 11101

Other trials in Honduras

About this study

Official title: Cosmetic Results With Tissue Adhesive (2-octylcyanoacrylate) vs. Subdermal Sutures in Cesarean Section: Single-blind Randomized Clinical Trial

Morbidity associated with post-cesarean wound closure, including cosmetically unfavorable scarring, is a significant concern in obstetrics, impacting patient satisfaction and recovery. Recent advances have introduced the use of tissue adhesives, such as 2-octylcyanoacrylate, which promise to improve cosmetic outcomes and reduce postoperative complications. This study will evaluate different tissue adhesive application schedules, keeping the total dose constant, to determine whether the method of application influences cosmetic results and the incidence of postoperative complications

Read the detailed description

In Honduras, as in many parts of the world, cesarean section is a common obstetric practice. The choice of wound closure method in this procedure has significant implications not only in terms of the patient's physical health, but also in her psychological and aesthetic well-being. The scar resulting from a cesarean section can have a lasting impact on a woman's perception of her own body, affecting her self-esteem and quality of life.

Historically, in Honduras, the use of subdermal sutures with nylon thread has been preferred for the closure of post-cesarean section wounds. However, with advances in medical technology, tissue adhesives have emerged as a promising alternative, potentially offering a better cosmetic outcome, faster application, and more comfortable recovery for the patient.

This study is crucial in the Honduran context for several reasons:

  1. improved Cosmetic Outcomes and Patient Satisfaction: By comparing two methods of wound closure, this study seeks to identify the technique that offers better cosmetic results, which could significantly improve the satisfaction and psychological well-being of patients undergoing elective cesarean sections.
  2. Adaptation to Local Resources: In a country like Honduras, where health resources may be limited, it is essential to optimize the use of technologies and surgical materials. This study will provide valuable information on the feasibility and efficacy of tissue adhesives compared to the traditional method, taking into account factors such as cost and availability of materials.
  3. Reduction of Postoperative Complications: By evaluating and comparing the incidence of complications associated with each closure method, the study could contribute to improve surgical practices and reduce the incidence of postoperative complications, which is of great relevance in the context of public health in Honduras.
  4. Impact on Resource Management in the Health System: In the context of a country with possibly limited health resources such as Honduras, it is essential to evaluate not only the clinical efficacy of surgical techniques, but also their cost-effectiveness. This study will provide information on the relative costs of the use of tissue adhesives compared to subdermal sutures, which is relevant for planning and resource allocation in the health system.
  5. Fostering Research and Evidence-Based Medicine in Honduras: This study will contribute to the growing need for contextualized medical research in Honduras, promoting the practice of evidence-based medicine that takes into account local realities and the specific needs of the population.

Objective: To evaluate the effects on morbidity and postoperative cosmetic outcomes of the use of tissue adhesive versus subdermal sutures in Pfannenstiel-type cesarean sections.

Being tested
2-octyl cyanoacrylate tissue adhesive applied continuously over the Pfannenstiel-type cesarean incision, subdermal suture
Keywords
Cesarean Wound Repair, Cesarean section scar, cosmetic appearance of cesarean scar, tissue adhesives

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 2-octyl cyanoacrylate tissue adhesive applied continuously over the Pfannenstiel-type cesarean incisionProcedure or surgery

    2-octyl cyanoacrylate tissue adhesive applied continuously over the Pfannenstiel-type cesarean incision

  • subdermal sutureProcedure or surgery

    wound closure with subdermal sutures using 2-0 nylon thread, under the same evaluation scheme

Study groups in NCT06760026
Study groupRoleWhat they receive
InterventionExperimentaluse 2-octyl cyanoacrylate tissue adhesive applied continuously over the Pfannenstiel-type cesarean incision
Receives: Procedure: 2-octyl cyanoacrylate tissue adhesive applied continuously over the Pfannenstiel-type cesarean incision
ControlActive comparatorwound closure with subdermal sutures using 2-0 nylon thread
Receives: Procedure: subdermal suture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in the OSAS Scale score

    The OSAS score is based on the assessment of several aspects of a scar, and each of these aspects is scored individually. Each variable uses a 10-point scoring system, where 1 represents normal foot. The scores of the individual variables can be added together to obtain a total score ranging from 5 to 50, where 5 represents normal skin.

    Items typically assessed include:

    • Vascularity: Refers to the presence of visible blood vessels or red coloration in the scar.
    • Pigmentation: Assesses whether the scar has a different color than the surrounding skin.
    • Thickness: Refers to the height or prominence of the scar above the level of the surrounding skin.
    • Relief: Assesses the texture of the scar compared to the surrounding skin.
    • Flexibility: Measures how stiff or flexible the scar is compared to the surrounding skin.

    Measured: One month from the first intervention until 6 months

Secondary outcomes (1)
  1. PSAS scale score

    The Patient Scar Assessment Scale (PSAS) consists of 6 items on scar-related pain, itching, color, stiffness, thickness, and irregularity. Each item uses a 10-point scoring system, summed to give a total score ranging from 6 to 60, where 6 represents normal skin with no associated symptoms.

    Measured: One month from the first intervention until 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jan 2025
  2. Study start1 Jan 2025
  3. Primary completion31 Jul 2025
  4. Study completion30 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Single-blind, parallel-group, randomized clinical trial of superiority
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06760026
Sponsor's protocol ID
PGO-UNAH-48-4-2025
Acronym
ADTID
Status last verified
Jan 2025
First submitted
30 Dec 2024
Last updated
17 Feb 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: It is not necessary, none of the 18 HIPAA identifiers will be placed

Publications

  • Cromi A, Ghezzi F, Gottardi A, Cherubino M, Uccella S, Valdatta L. Cosmetic outcomes of various skin closure methods following cesarean delivery: a randomized trial. Am J Obstet Gynecol. 2010 Jul;203(1):36.e1-8. doi: 10.1016/j.ajog.2010.02.001. Epub 2010 Apr 24.

    PubMed 20417924

Questions about this trial

What is this clinical trial studying?

A study testing 2-octyl cyanoacrylate tissue adhesive applied continuously over the Pfannenstiel-type cesarean incision and subdermal suture in people with Cesarean Wound Repair and Cesarean Section Scar, run by Ricardo A Gutierrez Ramirez, MD, MSc, FACOG at 1 site in Honduras.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Honduras. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in the OSAS Scale score (time frame: One month from the first intervention until 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06760026, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in